Ellen Scordino focuses on patent and trade secret litigation and client counseling in the pharmaceuticals, biologics, diagnostics, biofuels, and medical device industries but has also represented clients in a wide range of other patent and general commercial matters in courts across the country and in arbitrations.
She has particular expertise with Hatch-Waxman and BPCIA litigations and has led trial teams in obtaining favorable judgments and settlements in district courts and inter partes review proceedings. Scordino has also worked extensively with clients to create patent and litigation strategies mindful of regulatory issues and the FDA. She has litigated and counseled clients on matters involving blockbuster drugs, biologics and biosimilars, orphan drugs, PCR technologies, recombinant DNA technologies, medical devices, cannabis, biofuels, and chemistry (including food and consumer good additives).
CourtsSupreme Court of the United StatesUnited States Court of Appeals for the Federal CircuitUnited States Court of Appeals for the First CircuitUnited States District Court for the District of MassachusettsUnited States District Court for the Southern District of New YorkUnited States District Court for the Eastern District of New YorkUnited States District Court for the Eastern District of Michigan
J.D., Fordham University School of Law
B.S., Chemistry , Trinity College
Massachusetts Lawyers Weekly: Top Women of Law
Boston Business Journal: 40 Under 40
The Legal 500 United States 2021 - Recommended, Patent Litigation: Full Coverage Clients say, "Susan Krumplitsch and Ellen Scordino were valuable team members. Their responsiveness and excellent communication skills along with their flexibility made managing a complex dispute easy."
Co-Author, "AI Inventorship Decision Leaves Open Questions," Law360, September 17, 2021
Earlier in her career, Ellen was a research scientist and chemist.
Memberships And Affiliations
American Bar Association
New York Intellectual Property Law Association
Women in Bio
Women in Law Empowerment Forum (WILEF) – Global Advisory Board member and Boston Co-Chair
DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.
Unsolicited e-mails and information sent to DLA Piper or the independent DLA Piper Relationship firms will not be considered confidential, may be disclosed to others, may not receive a response, and do not create a lawyer-client relationship with DLA Piper or any of the DLA Piper Relationship firms. Please do not include any confidential information in this message. Also, please note that our lawyers do not seek to practice law in any jurisdiction in which they are not properly permitted to do so.